Internal Medicine, Gastroenterology · Deland, FL
NPI
1487603445
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1070 N Stone St, Suite D
Deland, FL, 32720
Phone (386) 822-9410
Medicare paid, 2024
$100K
1,026 services
Medicare patients, 2024
533
Average age 75
Drug cost, 2024
$349K
2,122 prescriptions
Company payments, 2025
$579
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin Gino F Prado was code 99214 (office e&m - established), 206 times for 166 patients. In total Martin Gino F Prado billed 1,026 services in 45 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 206 | 166 | $88.21 | $18K |
| 43239 Upper GI Endoscopy | Facility | 178 | 170 | $66.53 | $12K |
| 99222 Hospital E&M - Initial | Facility | 134 | 126 | $100.70 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 92 | 92 | $122.56 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 85 | 55 | $61.45 | $5,223 |
| 99231 Hospital E&M - Subsequent | Facility | 65 | 52 | $39.08 | $2,540 |
| 45385 Colonoscopy - Lesion Removal | Facility | 49 | 48 | $215.05 | $11K |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 45 | 45 | $185.78 | $8,360 |
| 99204 Office E&M - New | Office | 21 | 21 | $131.15 | $2,754 |
| 99213 Office E&M - Established | Office | 17 | 17 | $70.84 | $1,204 |
| 43249 Upper GI Endoscopy | Facility | 17 | 16 | $100.55 | $1,709 |
| 43235 Upper GI Endoscopy | Facility | 15 | 15 | $87.38 | $1,311 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 13 | 13 | $189.42 | $2,462 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $133.88 | $1,607 |
By year: 2022 $115K for 1,239 services; 2023 $132K for 1,405 services; 2024 $100K for 1,026 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin Gino F Prado prescribed most often to Medicare patients was Pantoprazole Sodium, with 816 prescriptions and refills. In total Martin Gino F Prado wrote 2,122 Medicare prescriptions that cost $349K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 816 | 2,323 | 328 | $12K |
| Famotidine Generic | 151 | 438 | 69 | $2,897 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 132 | 132 | 130 | $8,127 |
| Omeprazole Generic | 125 | 359 | 60 | $2,554 |
| Linzess Linaclotide | 72 | 124 | 17 | $65K |
| Sucralfate Generic | 54 | 102 | 24 | $7,013 |
| Dicyclomine Hcl Generic | 50 | 72 | 21 | $1,179 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 47 | 62 | 18 | $1,595 |
| Lactulose Generic | 42 | 69 | 17 | $1,196 |
| Esomeprazole Magnesium Generic | 36 | 94 | 18 | $1,133 |
| Sodium Chloride 0.9 % Sodium Chloride | 30 | 30 | Under 11 | $378 |
| Spironolactone Generic | 29 | 78 | 11 | $502 |
| Motegrity Prucalopride Succinate | 28 | 30 | Under 11 | $8,960 |
| Xifaxan Rifaximin | 27 | 27 | Under 11 | $87K |
| Furosemide Generic | 26 | 64 | Under 11 | $145 |
Brand drugs: 352 claims; generic drugs: 1,770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin Gino F Prado $579 ($579 in general payments such as food, travel and fees) from 7 companies. The largest payer was Boston Scientific Corporation with $257.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 3 | $257 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $131 |
| Abbvie Inc. ABBV | 4 | $82.99 |
| Celltrion USA Inc. 068270.KS | 1 | $32.21 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $29.87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $24.84 |
| Genzyme Corporation SNY | 1 | $20.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.